Literature DB >> 17408366

Potential of active and passive immunizations for the prevention and therapy of transmissible spongiform encephalopathies.

Steffen Bade1, Andreas Frey.   

Abstract

Transmissible spongiform encephalopathies are fatal neurodegenerative disorders that affect humans and certain animals and are caused by prions. In most cases, infection occurs by ingestion of prions. Their long-time persistence in the environment creates a reservoir of potentially infectious matter that renders the eradication of the disease problematic. Unfortunately, no cure is available to date. Yet, for both the treatment of infected and the protection of uninfected individuals, active and passive immunizations have been shown to have a beneficial effect on the course of the disease. The current review provides an overview of such antibody-based approaches and assesses their feasibility and potential in prophylaxis and therapy of transmissible spongiform encephalopathies.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17408366     DOI: 10.1586/14760584.6.2.153

Source DB:  PubMed          Journal:  Expert Rev Vaccines        ISSN: 1476-0584            Impact factor:   5.217


  5 in total

1.  [Innovative treatment approaches for Alzheimer's disease. Immunotherapy].

Authors:  R Dodel; M Bacher
Journal:  Nervenarzt       Date:  2008-11       Impact factor: 1.214

Review 2.  Immunotherapy for neurodegenerative diseases: focus on α-synucleinopathies.

Authors:  Elvira Valera; Eliezer Masliah
Journal:  Pharmacol Ther       Date:  2013-02-04       Impact factor: 12.310

Review 3.  Active and passive immunotherapy for neurodegenerative disorders.

Authors:  David L Brody; David M Holtzman
Journal:  Annu Rev Neurosci       Date:  2008       Impact factor: 12.449

Review 4.  Prion protein-specific antibodies-development, modes of action and therapeutics application.

Authors:  Tihana Lenac Rovis; Giuseppe Legname
Journal:  Viruses       Date:  2014-10-01       Impact factor: 5.048

5.  Generation of human scFvs antibodies recognizing a prion protein epitope expressed on the surface of human lymphoblastoid cells.

Authors:  Michela Flego; Alessandro Ascione; Silvia Zamboni; Maria L Dupuis; Valentina Imperiale; Maurizio Cianfriglia
Journal:  BMC Biotechnol       Date:  2007-07-02       Impact factor: 2.563

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.